CAMHS Prescribing Guidance During the COVID-19 Pandemic


** This guideline is currently under review**

Please continue to use this document as current guidance.


Use the button below to access this item.

Access this resource

Editorial Information

Last reviewed: 16/09/2020

Next review date: 01/09/2021

Author(s): Dr Jennifer Roxburgh, Naomi Booker, Dr Helen Smith, Professor Helen Minnis , Dr Jason Lang.

Version: 2021.02.05

Approved By: Drugs and Therapeutic Group; Mental Health and Learning Disabilities Drug & Therapeutic Committee

Reviewer name(s): Naomi Booker.

Document Id: November 2022